Emorfazone

CAS No. 38957-41-4

Emorfazone( PH011085 )

Catalog No. M24350 CAS No. 38957-41-4

Emorfazone has an anti-nociceptive effect.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 155 In Stock
5MG 172 In Stock
10MG 258 In Stock
25MG 426 In Stock
50MG 586 In Stock
100MG 792 In Stock
200MG 1051 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Emorfazone
  • Note
    Research use only, not for human use.
  • Brief Description
    Emorfazone has an anti-nociceptive effect.
  • Description
    Emorfazone has an anti-nociceptive effect.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PH011085
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    38957-41-4
  • Formula Weight
    239.27
  • Molecular Formula
    C11H17N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC(C(N(C)N=C1)=O)=C1N1CCOCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lintuzumab

    Lintuzumab (HuM-195) is a non-coupled humanized mouse monoclonal antibody directed against the cell-surface myelomonocyte differentiation antigen, CD33, with anti-leukemic activity that reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells.

  • PEG300

    PEG300 is a neutral polymer of molecular weight 300, is a water-soluble, low immunogenic and biocompatible polymer formed by repeating units of ethylene glycol.

  • PalythoaloneB

    Palythoalone B